Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The apparent interferon resistance of transmitted HIV-1 is possibly a consequence of enhanced replicative fitness

PLoS Pathogens(2022)10.1371/journal.ppat.1010973Source: DataRank Database

The apparent interferon resistance of transmitted HIV-1 is possibly a consequence of enhanced replicative fitness is a research paper published in PLoS Pathogens (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.50)OA: goldTopics (41)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Arthur Wickenhagen ORCID,Nardus Mollentze ORCID,Muhamad Afiq Aziz ORCID,Vattipally B. Sreenu ORCID,Sven Truxa ORCID

Live enrichment

PubMed:36399512 OpenAlex:https://openalex.org/W4309306162

Medical Research Council

Grant: MR/P022642/1

Host and Viral Determinants of Interferon Resistance During HIV-1 Transmission

Medical Research Council

Grant: MC_UU_12014/12

Viral Genomics and Bioinformatics

Medical Research Council

Grant: MC_UU_12018/12

Wellcome Trust

Grant: 201366/Z/16/Z

Wellcome Trust

Grant: 201366

Inhibition of HIV-1 by Type II Interferon

Wellcome Trust

Grant: unidentified

unidentified

Medical Research Council

Grant: MR/V01157X/1

Medical Research Council

Grant: MC_UU_12014/10

FWCI

0.50

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010973&type=printable

publisherhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010973&type=printable

publisherhttps://dx.plos.org/10.1371/journal.ppat.1010973

journalhttps://doi.org/10.1371/journal.ppat.1010973

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36399512

Fields of Study

HIV Research and TreatmentHepatitis C virus researchMathematical and Theoretical Epidemiology and Ecology Models0301 basic medicine0303 health sciences03 medical and health sciencesHumansInterferonsHIV-1Antiviral AgentsHIV SeropositivityDNA ReplicationDermatitis

MeSH Terms

Antiviral AgentsDermatitisDNA ReplicationHIV SeropositivityHumansInterferonsHIV-1

Keywords

BiologyInterferonVirologyTransmission (telecommunications)In vitroHuman immunodeficiency virus (HIV)EffectorGeneticsImmunologyDNA ReplicationQH301-705.5DermatitisRC581-607Antiviral AgentsHIV SeropositivityHIV-1HumansInterferonsImmunologic diseases. AllergyBiology (General)Research Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being